CBAP modulates Akt-dependent TSC2 phosphorylation to promote Rheb-mTORC1 signaling and growth of T-cell acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

CBAP modulates Akt-dependent TSC2 phosphorylation to promote Rheb-mTORC1 signaling and growth of T-cell acute lymphoblastic leukemia

Published:2018-09-28 Issue:9 Volume:38 Page:1432-1447
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Chiang Yun-Jung,Liao Wei-Ting,Ho Kun-Chin,Wang Shih-Hao,Chen Yu-Guang,Ho Ching-Liang,Huang Shiu-Feng,Shih Lee-Yung,Yang-Yen Hsin-Fang,Yen Jeffrey Jong-Young

Funder

Ministry of Science and Technology, Taiwan

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/s41388-018-0507-6.pdf

Reference44 articles.

1. Roti G, Stegmaier K. New approaches to target T-ALL. Front Oncol. 2014;4:170.

2. Silverman LB, Gelber RD, Young ML, Dalton VK, Barr RD, Sallan SE. Induction failure in acute lymphoblastic leukemia of childhood. Cancer. 1999;85:1395–404.

3. Gokbuget N, Stanze D, Beck J, Diedrich H, Horst HA, Huttmann A, et al. Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation. Blood. 2012;120:2032–41.

4. You MJ, Medeiros LJ, Hsi ED. T-lymphoblastic leukemia/lymphoma. Am J Clin Pathol. 2015;144:411–22.

5. Palomero T, Sulis ML, Cortina M, Real PJ, Barnes K, Ciofani M, et al. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med. 2007;13:1203–10.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into diosgenin against inflammatory bowel disease as functional food based on network pharmacology and molecular docking;Heliyon;2024-09

2. CBAP regulates the function of Akt-associated TSC protein complexes to modulate mTORC1 signaling;Journal of Biological Chemistry;2023-12

3. Endothelial Progenitor-Cell-Derived Exosomes Induced by Astragaloside IV Accelerate Type I Diabetic-wound Healing via the PI3K/AKT/mTOR Pathway in Rats;Frontiers in Bioscience-Landmark;2023-11-08

4. PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer;Molecular Cancer;2023-08-18

5. An insight into PI3k/Akt pathway and associated protein–protein interactions in metabolic syndrome: A recent update;Journal of Cellular Biochemistry;2023-07